Skip to main content
Log in

Single and repeated administration of neuroleptic drugs to rats: Effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa

  • Animal Studies
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Injection of tranylcypromine and L-tryptophan results in rats displaying behavioural changes including hyperactivity, probably due to stimulation of post-synaptic 5-hydroxytryptamine (5-HT) receptors. Increased locomotor activity of a different type is elicited by injection of tranylcypromine and L-dopa, a procedure which increased dopaminergic function in the brain. It has now been demonstrated that the neuroleptic drugs, chlorpromazine, α-flupenthixol, haloperidol and spiroperidol block both syndromes. The inhibition produced by these drugs on 5-HT-induced hyperactivity is probably because a dopaminergic system is involved in the behavioural expression of the 5-HT induced hyperactivity. The structurally related drugs with no neuroleptic activity (ethopropazine, promethazine and β-flupenthixol) are without effect on these hyperactivity syndromes. Also ineffective were the neuroleptics pimozide and clozapine.

Striatal dopamine sensitive adenylate cyclase activity in vitro was inhibited by the administration of chlorpromazine (100 mg/kg) in vivo.

Rats treated for 4 or more days with chlorpromazine, α-flupenthixol, spiroperidol and haloperidol subsequently showed enhanced locomotor activity in response to tranylcypromine and L-Dopa. Administration of those drugs which did not block hyperactivity acutely did not result in enhancement. Only chlorpromazine, when given for 4 days, enhanced the hyperactivity response following tranylcypromine and L-tryptophan, probably because the drug also blocks 5-HT receptors.

In rats displaying enhanced behavioural responses no evidence was found for enhanced sensitivity of striatal adenylate cyclase to dopamine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Boullin, D. J., Grahame-Smith, D. G., Grimes, R. P. J., Woods, H. F.: Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlopromazine and its metabolites. Brit. J. Pharmacol. 53, 121–125 (1975a)

    Google Scholar 

  • Boullin, D. J., Woods, H. F., Grimes, R. P. J., Grahame-Smith, D. G., Wiles, D., Gelder, M. G., Kolakowska, T.: Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. Brit. J. clin. Pharmacol. 2, 29–35 (1975b)

    Google Scholar 

  • Bradley, P. B., Wolstencroft, J. H., Hösli, L., Avanzino, G. L.: Neuronal basis for the central actions of chlorpromazine. Nature (Lond.) 212, 1425–1427 (1966)

    Google Scholar 

  • Brown, B. L., Albano, J. D. M., Ekins, R. P., Sgherzi, A. M., Tampion, W.: A simple and sensitive saturation assay method for the measurement of Adenosine 3′ 5′-cyclic monophosphate. Biochem. J. 121, 561–562 (1971)

    Google Scholar 

  • Buus Lassen, J.: Inhibition of 4, α-dimethyl-m-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chlorpromazine, haloperidol, clozapine and thioridazine. Psychopharmacologia (Berl.) 43, 25–29 (1975)

    Google Scholar 

  • Clement-Cormier, Y. L., Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc. nat. Acad. Sci. (Wash.) 171, 1113–1117 (1974)

    Google Scholar 

  • Costall, B., Naylor, R. J.: Neuroleptic antagonism of dyskinetic phenomena. Europ. J. Pharmacol. 33, 301–312 (1975)

    Google Scholar 

  • Crow, T. J., Gilbe, D.: Dopamine antagonism and antischizophrenic potency of neuroleptic drugs. Nature New Biol. 245, 27–28 (1973)

    Google Scholar 

  • De Maio, D.: Clozapin, a novel major tranquilliser. Arzneimittel-Forsch. 22, 919–923 (1972)

    Google Scholar 

  • Gianutsos, G., Drawbaugh, R. B., Hynes, M. D., Lal, H.: Behavioural evidence for dopaminergic supersensitivity after chronic haloperidol. Life Sci. 14, 887–898 (1974)

    Google Scholar 

  • Grahame-Smith, D. G.: Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J. Neurochem. 18, 1053–1066 (1971a)

    Google Scholar 

  • Grahame-Smith, D. G.: Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor. Brit. J. Pharmacol. 43, 856–864 (1971b)

    Google Scholar 

  • Green, A. R., Grahame-Smith, D. G.: The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Neuropharmacology 13, 949–959 (1974)

    Google Scholar 

  • Green, A. R., Grahame-Smith, D. G.: The effect of drugs on the factors controlling the functional activity of brain 5-hydroxytryptamine. Nature (Lond.) 260, 487–491 (1976)

    Google Scholar 

  • Green, A. R., Kelly, P. H.: Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-Dopa. Brit. J. Pharmacol. 57, 141–147 (1976)

    Google Scholar 

  • Green, A. R., Tordoff, A. F. C., Bloomfield, M. R.: Elevation of brain GABA concentrations with amino-oxycetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. J. neural Trans. (in press, 1976)

  • von Gross, H., Langner, E.: Das Neuroleptikum 100-129/HF-1854 (Clozapin) in der Psychiatrie. Int. Pharmacopsychiat. 4, 220–230 (1970)

    Google Scholar 

  • von Gross, H., Langner, E.: Das Wirkungprofil eines chemisch neuartigen Breitbandneuroleptikums der Dibenzodiazepingruppe. Wien. med. Wschr. 40, 814–816 (1966)

    Google Scholar 

  • Haase, H. J., Blannenburg-Zahn, M., Koester, H., Neuhaus, B.: Zur Frage der therapeutischen Wirksamkeit eines Neuroleptikums bei chronisch Schizophrenen mit Dosierungen oberhalb und unterhalb der “neuroleptischen Schwelle” (am Beispiel des Neuroleptikums Pimozide). Int. Pharmacopsychiat. 3, 1–12 (1969)

    Google Scholar 

  • Horn, A. S., Cuello, A. E., Miller, R. J.: Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity. J. Neurochem. 22, 265–270 (1974)

    Google Scholar 

  • von Hungen, K., Roberts, S., Hill, D. F.: Serotonin sensitive adenylate cyclase activity in immature rat brain. Brain Res. 84, 257–267 (1975)

    Google Scholar 

  • Ionescu, R., Nica, S. V., Oproiu, L., Niturad, A., Tudorache, B.: Double-blind study in psychopathic behaviour disorders (clozapine and pericyanine). Pharmacopsychiat. 6, 294–299 (1973)

    Google Scholar 

  • Iversen, L. L.: Dopamine receptors in the brain. Science 188, 1084–1089 (1975a)

    Google Scholar 

  • Iversen, L. L.: Summing up. Advanc. Neurol. 9, 415–418 (1975b)

    Google Scholar 

  • Iwatsubo, K., Clouet, D. H.: Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine or haloperidol. Biochem. Pharmacol. 24, 1499–1503 (1975)

    Google Scholar 

  • Jacobs, B. L.: Effect of two dopamine receptor blockers on a serotonin-mediated behavioural syndrome in rats. Europ. J. Pharmacol. 27, 363–366 (1974)

    Google Scholar 

  • Karobath, M. E.: Tricyclic antidepressive drugs and dopaminesensitive adenylate cyclase from rat brain striatum. Europ. J. Pharmacol. 30, 159–163 (1975)

    Google Scholar 

  • Kebabian, J. W., Clement-Cormier, Y. C., Petzold, G. L., Greengard, P.: Chemistry of dopamine receptors. Advanc. Neurol 9, 1–11 (1975)

    Google Scholar 

  • Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine-sensitive adenylate cyclase in the caudate nucleus of the rat brain and its similarity to the “dopamine receptor”. Proc. nat. Acad. Sci. (Wash.) 69, 2145–2149 (1972)

    Google Scholar 

  • Kelly, P. H.: Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and drug induced rotation in rats. Brain Res. 100, 163–169 (1975)

    Google Scholar 

  • Kelly, P. H., Miller, R. J.: The interaction of neuroleptic and muscarinic agents with central dopaminergic systems. Brit. J. Pharmacol. 54, 115–121 (1975)

    Google Scholar 

  • Kelly, P. H., Seviour, P. W., Iversen, S. D.: Amphetamine and apomorphine responses in the rat, 6-OHDA lesions of the nucleus acumbens septi and corpus striatum. Brain Res. 94, 507–522 (1975)

    Google Scholar 

  • Klawans, H. L., D'Amico, D. J., Patel, B. C.: Behavioural supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment. Psychopharmacologia (Berl.) 44, 297–300 (1975)

    Google Scholar 

  • Laduron, P.: Limiting factors in the antagonism of neuroleptic drugs on dopamine-sensitive adenylate cyclase. J. Pharm. Pharmacol. 28, 250–251 (1976)

    Google Scholar 

  • Manian, A. A., Efron, D. H., Goldberg, M. A.: A comparative pharmacological study of a series of monohydroxylated and methoxylated chlorpromazine derivatives in the central nervous system. Life Sci. 4, 2425–2438 (1965)

    Google Scholar 

  • Miller, R. J., Hiley, C. R.: Antimuscarinic properties of neuroleptic drugs and drugs induced parkinsonism. Nature (Lond.) 248, 596–597 (1974)

    Google Scholar 

  • Miller, R. J., Hiley, R.: Antimuscarinic actions of neuroleptic drugs. Advanc. Neurol. 9, 141–154 (1975)

    Google Scholar 

  • Miller, R. J., Horn, A. S., Iversen, L. L.: The action of neuroleptic drugs on dopamine stimulated adenosine 3′ 5′-monophosphate production in rat neostriatum and limbic forebrain. Molec. Pharmacol. 10, 759–766 (1974)

    Google Scholar 

  • Mishra, R. K., Gardner, E. L., Katzman, R., Makman, M. H.: Enhancement of dopamine-stimulated adenylated cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity. Proc. nat. Acad. Sci. (Wash.) 71, 3883–3887 (1974)

    Google Scholar 

  • Moore, K. E., Thornburg, J. E.: Drug induced dopaminergic supersensitivity. Advanc. Neurol. 9, 93–104 (1975)

    Google Scholar 

  • Nybäck, H., Schubert, J., Sedvall, G.: Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain. J. Pharm. Pharmacol. 22, 622–624 (1970)

    Google Scholar 

  • Pellegrino, L. J., Cushman, A. J.: A stereotaxic atlas of the rat brain. New York: Appleton-Century-Crofts, 1967

    Google Scholar 

  • Posner, H. S., Hearst, E., Taylor, W. L., Losmides, G. J.: Model metabolites of chlopromazine and promazine: relative activities in some pharmacological and behavioural tests. J. Pharmacol. exp. Ther. 137, 84–90 (1962)

    Google Scholar 

  • Snyder, S. H., Greenberg, D. E., Yamamura, H.: Antischizophrenic drug and brain cholinergic receptors: affinity for muscarinic sites predicts extrapyramidal effects. Arch. gen. Psychiat. 31, 58–62 (1974)

    Google Scholar 

  • Sterkmans, P., Brugmans, J., Gevers, F.: The clinical efficacy of pimozide in chronic psychiatic patients. Clin. Trials. J. 5, 1107–1112 (1968)

    Google Scholar 

  • Stille, G., Hippius, H.: Kritische Stellungnahme zum Begriff der Neuroleptika. Pharmacopsychiat. 4, 182–191 (1971)

    Google Scholar 

  • Stille, G., Lauener, H., Eichenberger, E.: The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (v.e) (1,4) diazepine (clozapine). Farmaco, Edprat. 26, 603–625 (1971)

    Google Scholar 

  • Thornburg, J. E., Moore, K. E.: The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs. Neuropharmacology 12, 853–866 (1973)

    Google Scholar 

  • Turano, P., Turner, W. J., Manian, A. A.: Thin layer chromatography of chlorpromazine metabolites. Attempts to identify each of the metabolites appearing in blood, urine and feces of chronically medicated schizophrenics. J. Chromatogr. 75, 277–293 (1973)

    Google Scholar 

  • Ungerstedt, U.: Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta physicol scand. 83, Suppl. 367, 49–68 (1971)

    Google Scholar 

  • Ungerstedt, U., Ljungberg, T., Hoffer, B., Siggins, G.: Dopaminergic supersensitivity in the striatum. Advanc. Neurol. 9, 57–65 (1975)

    Google Scholar 

  • von Voigtlander, P. F., Boukma, S. J., Johnson, G. A.: Dopaminergic denervation supersensitivity and dopamine stimulated adenyl cyclase activity. Neuropharmacology 12, 1081–1086 (1973)

    Google Scholar 

  • von Voigtlander, P. F., Losey, E. G., Triezenberg, H.: Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. J. Pharmacol. exp. Ther. 193, 88–94 (1975)

    Google Scholar 

  • Wilk, S., Watson, E., Stanley, M. E.: Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and clozapine. J. Pharmacol. exp. Ther. 195, 265–270 (1975)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heal, D.J., Green, A.R., Boullin, D.J. et al. Single and repeated administration of neuroleptic drugs to rats: Effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa. Psychopharmacology 49, 287–300 (1976). https://doi.org/10.1007/BF00426832

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00426832

Keywords

Navigation